rs150850005

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_005045.4(RELN):​c.1483A>G​(p.Ile495Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000968 in 1,611,640 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I495T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00034 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000072 ( 1 hom. )

Consequence

RELN
NM_005045.4 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:1

Conservation

PhyloP100: 1.13

Publications

2 publications found
Variant links:
Genes affected
RELN (HGNC:9957): (reelin) This gene encodes a large secreted extracellular matrix protein thought to control cell-cell interactions critical for cell positioning and neuronal migration during brain development. This protein may be involved in schizophrenia, autism, bipolar disorder, major depression and in migration defects associated with temporal lobe epilepsy. Mutations of this gene are associated with autosomal recessive lissencephaly with cerebellar hypoplasia. Two transcript variants encoding distinct isoforms have been identified for this gene. Other transcript variants have been described but their full length nature has not been determined. [provided by RefSeq, Jul 2008]
RELN Gene-Disease associations (from GenCC):
  • lissencephaly with cerebellar hypoplasia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Norman-Roberts syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P, PanelApp Australia
  • familial temporal lobe epilepsy 7
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal dominant epilepsy with auditory features
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ankylosing spondylitis
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.051508456).
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000335 (51/152150) while in subpopulation AMR AF = 0.00282 (43/15264). AF 95% confidence interval is 0.00215. There are 1 homozygotes in GnomAd4. There are 36 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RELNNM_005045.4 linkc.1483A>G p.Ile495Val missense_variant Exon 13 of 65 ENST00000428762.6 NP_005036.2 P78509-1
RELNNM_173054.3 linkc.1483A>G p.Ile495Val missense_variant Exon 13 of 64 NP_774959.1 P78509-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RELNENST00000428762.6 linkc.1483A>G p.Ile495Val missense_variant Exon 13 of 65 5 NM_005045.4 ENSP00000392423.1 P78509-1

Frequencies

GnomAD3 genomes
AF:
0.000335
AC:
51
AN:
152032
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00282
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0000883
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000188
AC:
47
AN:
250440
AF XY:
0.000207
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000872
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000115
Gnomad OTH exome
AF:
0.000492
GnomAD4 exome
AF:
0.0000719
AC:
105
AN:
1459490
Hom.:
1
Cov.:
29
AF XY:
0.0000923
AC XY:
67
AN XY:
726172
show subpopulations
African (AFR)
AF:
0.000240
AC:
8
AN:
33382
American (AMR)
AF:
0.000651
AC:
29
AN:
44554
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26062
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39624
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86228
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53368
Middle Eastern (MID)
AF:
0.00435
AC:
25
AN:
5744
European-Non Finnish (NFE)
AF:
0.0000270
AC:
30
AN:
1110262
Other (OTH)
AF:
0.000183
AC:
11
AN:
60266
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000335
AC:
51
AN:
152150
Hom.:
1
Cov.:
32
AF XY:
0.000484
AC XY:
36
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41550
American (AMR)
AF:
0.00282
AC:
43
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5162
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0000883
AC:
6
AN:
67956
Other (OTH)
AF:
0.00
AC:
0
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000796
Hom.:
0
Bravo
AF:
0.000427
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000107
AC:
13
EpiCase
AF:
0.000164
EpiControl
AF:
0.000178

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:2
Apr 16, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 13, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: RELN c.1483A>G (p.Ile495Val) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00019 in 250440 control chromosomes in the gnomAD database, including 1 homozygote. To our knowledge, no occurrence of c.1483A>G in individuals affected with Epilepsy Familial Temporal Lobe 7 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 212032). Based on the evidence outlined above, the variant was classified as VUS-possibly benign. -

not provided Uncertain:1
Sep 27, 2017
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The I495V variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. This variant is observed in28/34226 (0.08%) alleles from individuals of Latino background, including 1 homozygous individual (Lek et al., 2016). The I495V variant is a conservative amino acid substitution, which is not likely to impact secondary proteinstructure as these residues share similar properties. This substitution occurs at a position that is not conserved, and in silico analysis predicts this variant likely does not alter the protein structure/function. Based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. -

Norman-Roberts syndrome;C4225327:Familial temporal lobe epilepsy 7;CN030884:Epilepsy, familial temporal lobe, 1 Uncertain:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Norman-Roberts syndrome;C4225327:Familial temporal lobe epilepsy 7 Benign:1
Jan 08, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
7.7
DANN
Benign
0.61
DEOGEN2
Benign
0.062
T;.;.
Eigen
Benign
-0.75
Eigen_PC
Benign
-0.65
FATHMM_MKL
Benign
0.53
D
LIST_S2
Benign
0.75
T;T;T
M_CAP
Benign
0.0061
T
MetaRNN
Benign
0.052
T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.20
N;N;.
PhyloP100
1.1
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.11
N;N;N
REVEL
Benign
0.023
Sift
Benign
0.30
T;T;T
Sift4G
Benign
0.65
T;T;T
Polyphen
0.0040
B;B;.
Vest4
0.17
MVP
0.043
MPC
0.14
ClinPred
0.011
T
GERP RS
0.58
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.029
gMVP
0.24
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150850005; hg19: chr7-103294611; API